IRIS
PERUCCA, EMILIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.900
AS - Asia 10.656
EU - Europa 7.875
SA - Sud America 1.276
Continente sconosciuto - Info sul continente non disponibili 390
AF - Africa 334
OC - Oceania 29
Totale 36.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.551
CN - Cina 5.257
SG - Singapore 2.362
IE - Irlanda 1.776
UA - Ucraina 1.386
HK - Hong Kong 1.137
BR - Brasile 957
DE - Germania 875
RU - Federazione Russa 797
VN - Vietnam 773
FI - Finlandia 619
FR - Francia 579
IT - Italia 546
SE - Svezia 457
GB - Regno Unito 452
IN - India 232
BD - Bangladesh 194
CA - Canada 177
ZA - Sudafrica 147
AR - Argentina 97
JP - Giappone 90
IQ - Iraq 89
MX - Messico 75
TR - Turchia 71
PL - Polonia 70
NL - Olanda 60
PK - Pakistan 59
ID - Indonesia 57
CO - Colombia 50
ES - Italia 43
UZ - Uzbekistan 42
VE - Venezuela 42
EC - Ecuador 40
SA - Arabia Saudita 40
MY - Malesia 37
BE - Belgio 36
KE - Kenya 34
PH - Filippine 34
CL - Cile 30
AT - Austria 29
EG - Egitto 27
TN - Tunisia 26
AU - Australia 23
IL - Israele 23
AE - Emirati Arabi Uniti 22
MA - Marocco 22
PE - Perù 20
LT - Lituania 19
PY - Paraguay 18
CR - Costa Rica 17
CZ - Repubblica Ceca 16
IR - Iran 16
JM - Giamaica 14
MU - Mauritius 14
NI - Nicaragua 14
DZ - Algeria 13
JO - Giordania 13
KR - Corea 13
SI - Slovenia 12
AZ - Azerbaigian 11
BG - Bulgaria 11
ET - Etiopia 10
SK - Slovacchia (Repubblica Slovacca) 10
TH - Thailandia 10
EU - Europa 9
NP - Nepal 9
PS - Palestinian Territory 9
RO - Romania 9
UY - Uruguay 9
CH - Svizzera 8
DO - Repubblica Dominicana 8
PA - Panama 8
SN - Senegal 8
GR - Grecia 7
HN - Honduras 7
KZ - Kazakistan 7
SV - El Salvador 7
TW - Taiwan 7
BO - Bolivia 6
BY - Bielorussia 6
KG - Kirghizistan 6
TT - Trinidad e Tobago 6
AL - Albania 5
AO - Angola 5
EE - Estonia 5
HR - Croazia 5
IS - Islanda 5
LK - Sri Lanka 5
MD - Moldavia 5
NO - Norvegia 5
RS - Serbia 5
LV - Lettonia 4
OM - Oman 4
PR - Porto Rico 4
QA - Qatar 4
AM - Armenia 3
BH - Bahrain 3
GA - Gabon 3
HU - Ungheria 3
LB - Libano 3
Totale 36.005
Salva come PNG Salva come JPEG
Città #
Chandler 1.861
Dublin 1.776
Jacksonville 1.664
San Jose 1.396
Ashburn 1.257
Nanjing 1.224
Singapore 1.210
Dallas 1.142
Hong Kong 1.111
Boardman 618
Beijing 575
Council Bluffs 516
Nanchang 472
Princeton 449
Lawrence 417
Wilmington 416
Los Angeles 374
Lauterbourg 371
Shenyang 360
Changsha 354
Hebei 347
Ho Chi Minh City 281
Jiaxing 279
Medford 270
Tianjin 219
Hangzhou 198
Hanoi 188
Buffalo 186
Ann Arbor 175
New York 164
Redondo Beach 164
Helsinki 160
Woodbridge 127
Santa Clara 123
Johannesburg 120
Milan 120
Moscow 114
Shanghai 106
Fairfield 91
Houston 90
São Paulo 88
Saint Petersburg 85
Chicago 77
Tokyo 75
Verona 75
Norwalk 71
Orem 69
San Francisco 69
Toronto 68
Munich 67
The Dalles 64
Seattle 59
Brooklyn 56
Frankfurt am Main 54
Cambridge 51
Warsaw 48
Atlanta 45
Columbus 44
Des Moines 44
Chennai 43
Da Nang 38
Guangzhou 38
Baghdad 37
Denver 37
Tashkent 36
Zhengzhou 36
London 35
Brussels 33
Montreal 33
Kunming 32
Nuremberg 30
Phoenix 30
Pune 30
Pavia 29
Turku 28
Falls Church 27
Jinan 27
Dhaka 26
Nairobi 26
Falkenstein 25
Haiphong 25
Rio de Janeiro 25
Charlotte 24
Mexico City 24
Rome 24
Dearborn 23
Amsterdam 21
Boston 21
Curitiba 21
Belo Horizonte 20
Piscataway 20
Taizhou 20
Washington 20
Stockholm 19
Manchester 18
Mumbai 18
Jeddah 17
Lahore 17
Tunis 17
Cairo 16
Totale 23.380
Salva come PNG Salva come JPEG
Nome #
ILAE Official Report: A practical clinical definition of epilepsy 401
Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. 302
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. 250
A comparative study of free plasma choline levels following intramuscular administration of L-alpha-glycerylphosphorylcholine and citicoline in normal volunteers. 232
ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology 184
Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and puerperium. 183
A simple and rapid HPLC-UV method for the determination of retigabine in human plasma 172
Induction of ethinylestradiol and levonorgestrel metabolism by oxcarbamazepine in healthy women 169
A novel enantioselective microassay for the high-performance liquid chromatography determination of oxcarbazepine and its active metabolite monohydroxycarbazepine in human plasma 166
A multicenter randomized controlled trial on the clinical impact of therapeutic drug monitoring in patients with newly diagnosed epilepsy. 164
Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry 164
Development and validation of an HPLC-UV detection assay for the determination of rufinamide in human plasma and saliva. 162
A multicenter, randomized, placebo-controlled trial of levetiracetam in children and adolescents with newly diagnosed absence epilepsy. 161
A multiparametric investigation of daytime sleepiness and psychomotor functions in epileptic patients treated with phenobarbital and sodium valproate: a comparative controlled study 160
Alterazioni del campo visivo in soggetti epilettici in trattamento cronico con vigabatrin. 154
No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk—An analysis of Finnish health register and German health insurance data 154
A Double-Blind, Placebo-Controlled Study on the Effect of Vigabatrin on In Vivo Parameters of Hepatic Microsomal Enzyme Induction and on the Kinetics of Steroid Oral Contraceptives in Healthy Female Volunteers 150
A PHARMACOLOGICAL AND CLINICAL REVIEW ON TOPIRAMATE, A NEW ANTIEPILEPTIC DRUG, 147
Basal Ganglia Dysmorphism in Patients With Aicardi Syndrome 144
A Prospective study on the effects of antiepileptic drugs on the human foetus: The European Registry initiative 141
Six-year follow-up study on the efficacy and safety of vigabatrin in patients with epilepsy. 139
Low risk pragmatic trials do not always require participants' informed consent 138
Characteristics of a large population of patients with refractory epilepsy attending tertiary referral centers in Italy. on behalf of the SOPHIE Study Group. 132
Changes in lamotrigine pharmacokinetics during pregnancy and the puerperium. 132
Drug interactions with nimesulide. 129
Clinical pharmacokinetics of fluvoxamine. 129
Stereoselective determination of vigabatrin enantiomers in human plasma by high performance liquid chromatography using UV detection. 128
Increased Apparent Oral Clearance of Valproic Acid during Intake of Combined Contraceptive Steroids in Women with Epilepsy 127
A web-based algorithm to rapidly classify seizures for the purpose of drug selection 127
Plasma concentrations of the enantiomers of fluoxetine and norfluoxetine sources of variability and preliminary observations on relations with clinical response. 125
Enantioselective effects of levodropropizine and dropropizine on psychomotor functions in normal volunteers: a placebo-controlled, double-blind comparative study. 125
A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy 124
Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. 123
A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy. 122
Novel Medications for Epilepsy 120
Definition of drug resistant epilepsy: Consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia (Oxford) 51, 1069-1077, 2010 120
Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age 120
Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring 119
Concentrations of L-dopa in plasma and plasma ultrafiltrates. 118
Effect of enzyme inducing anticonvulsants on ethosuximide pharmacokinetics in epileptic patients. 118
Antiepileptic drug use and epileptic seizures in nursing home residents in the Province of Pavia, Italy: A reappraisal 12 years after a first survey 118
Choreiform syndrome associated with fluoxetine treatment in a patient with deficient CYP2D6 activity. 118
Omeprazole Does Not Enhance the Metabolism of Phenacetin, a Marker of CYP1A2 Activity, in Healthy Volunteers 116
Effects of phenytoin on the in vivo kinetics of thiamine and its phosphoesters in rat nervous tissues 116
Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.SOPHIE Study Group. 116
A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients. Commentary. 116
2017 International League Against Epilepsy classifications of seizures and epilepsy are steps in the right direction 116
Effect of active and passive cigarette smoking on CYP1A2-mediated phenacetin disposition in Chinese subjects. 116
Does screening for adverse effects improve health outcomes in epilepsy? A randomized trial 116
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe 116
Measurement of seizure freedom in adjunctive therapy studies in refractory partial epilepsy: the levetiracetam experience 114
Sertraline-induced potentiation of the CYP3A4-dependent neurotoxicity of carbamazepine: An in vitro study 114
Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. 113
Development and validation of an HPLC-UV assay for the therapeutic monitoring of the new antiepileptic drug perampanel in human plasma 112
Daytime sleepiness in healthy university students: A multiparametric study 110
Reversible Pseudoatrophy of the Brain and Mental Deterioration Associated with Valproate Treatment 110
A comparative study of the effect of carbamazepine and valproic acid on the pharmacokinetics and metabolic profile of topiramate at steady state in patients with epilepsy 110
Comparative pharmacokinetics and pharmacodynamics of eterobarbital and phenobarbital in normal volunteers. 110
Clinical significance of pharmacokinetic interactions between antiepileptic and psychotropic drugs. 109
Pharmacokinetic variability of new antiepileptic drugs at different ages. 109
Influence of aging on serum phenytoin concentrations: A pharmacokinetic analysis based on therapeutic drug monitoring data. 109
Inhibition of risperidone metabolism by fluoxetine in patients with schizophrenia: A clinically relevant pharmacokinetic drug interaction 109
Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. 109
THE INFLUENCE OF OLD AGE AND ENZYME INDUCING COMEDICATION ON THE PHARMACOKINETICS OF VALPROIC ACID AT STEADY STATE: A CASE-MATCHED EVALUATION BASED ON THERAPEUTIC DRUG MONITORING DATA. 109
Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). 108
DIFFERENTIAL-EFFECTS OF VALPROIC ACID AND ENZYME-INDUCING ANTICONVULSANTS ON NIMODIPINE PHARMACOKINETICS IN EPILEPTIC PATIENTS 108
The new antiepileptic drugs: Pharmacological and clinical aspects. 107
Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects 107
Novel frontiers in epilepsy treatments: preventing epileptogenesis by targeting inflammation 107
Inhibition of diazepam metabolism by fluvoxamine: a pharmacokinetic study in normal volunteers. 107
Valproic acid after five decades of use in epilepsy: Time to reconsider the indications of a time-honoured drug 105
The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction 104
Epilessia nell'anziano:dati dai registri di un centro neurologico. 104
Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs. 104
Influence of CYP2C9, 2C19 and 2D6 genetic polymorphisms on the steady-state plasma concentrations of the enantiomers of fluoxetine and norfluoxetine. 104
Add-on lamotrigine treatment in children and young adults with severe partial epilepsy: a open, prospective, long-term study 103
Withdrawing antiepileptic drugs in seizure-free patients: what are the cognitive benefits? 103
Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects 103
Overtreatment in epilepsy: adverse consequences and mechanisms. 102
The Influence of Dosage, Age, and Comedication on Steady State Plasma Lamotrigine Concentrations in Epileptic Children 102
Therapeutic strategies against epilepsy in Mediterranean countries: a report from an international collaborative survey. 102
Vigabatrin and epilepsy. Lessons learned. 101
Fetal exposure to GABA-acting antiepileptic drugs generates hippocampal and cortical dysplasias. 101
CYP2D6-related oxidation polymorphism in Italy 101
Patterns of prescription of antiepileptic drugs in patients with refractory epilepsy at tertiary referral centres in Italy. 100
A pragmatic algorithm to select appropriate antiseizure medications in patients with epilepsy 100
Cost minimization analysis of antiepileptic drugs in newly diagnosed epilepsy in 12 European countries 99
Plasma gabapentin concentrations in children with epilepsy: Influence of age, relationship with dosage, and preliminary observations on correlation with clinical response 99
Topiramate pharmacokinetics in children and adults with epilepsy: A case-matched comparison based on therapeutic drug monitoring data. 99
A new classification is born 99
Erratum The long-term effect of vagus nerve stimulation on quality of life in patients with pharmacoresistant focal epilepsy: The PuLsE (Open Prospective Randomized Long-term Effectiveness) trial (Epilepsia (2014) 55 (893-900) 98
Farmacocinetica delle benzodiazepine. 98
Progress report on new antiepileptic drugs: a summary of the Fourth Eilat Conference 98
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes 98
Role of valproate across the ages. Treatment of epilepsy in the elderly 97
Phenobarbital pharmacokinetics in old age: A case-matched evaluation based on therapeutic drug monitoring data. 97
Epilepsy: new advances. 97
Seizure control and treatment in pregnancy. Observations from the EURAP Epilepsy Pregnancy Registry 97
The remarkable story of valproic acid 97
A summary of data presented at the XIV conference on new antiepileptic drug and devices (EILAT XIV) 97
Totale 12.639
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.179
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.179
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.601 0 5 64 21 20 36 27 101 100 18 275 934
2022/20235.273 641 314 37 471 518 593 0 355 2.110 25 136 73
2023/20241.577 222 281 58 137 170 413 30 107 11 45 60 43
2024/20254.438 141 480 126 178 74 186 145 366 978 166 477 1.121
2025/202611.669 786 1.085 1.420 1.059 1.177 460 2.312 467 873 833 759 438
2026/20271.781 882 899 0 0 0 0 0 0 0 0 0 0
Totale 36.460